Design, synthesis, and evaluation of 2-alkoxydihydrocinnamates as PPAR agonists
摘要:
A series of 2-alkoxydihydrocinnamates were synthesized as PPAR gamma and PPAR alpha dual agonists. In vitro studies in cell model showed that these compounds were efficacious. Compound 1g was found to be a potent PPAR alpha/gamma dual agonist and will be further evaluated for the treatment of type II diabetes. (c) 2006 Published by Elsevier Ltd.
A compound having the structure
useful for treatment or prevention of cardiovascular diseases, endothelial dysfunction, diastolic dysfunction, atherosclerosis, hypertension, angina pectoris, thromboses, restenoses, myocardial infarction, strokes, cardiac insufficiency, pulmonary hypertonia, erectile dysfunction, asthma bronchiale, chronic kidney insufficiency, diabetes, or cirrhosis of the liver in a human or animal patient.
mechanism was composed of the nucleophilic addition reaction of hydroperoxide anion, dioxetanone ring formation, and nonadiabatic transition due to spin–orbit coupling around the transition state (TS) to the triplet state (T1) following the decomposition pathway. The TS which appeared in the thermaldecomposition would be a rate-determining step for all three processes.
Palladium Supported on Zinc Oxide Nanoparticles as Efficient Heterogeneous Catalyst for<i>SuzukiMiyaura</i>and<i>Hiyama</i>Reactions under Normal Laboratory Conditions
作者:Mona Hosseini-Sarvari、Zahra Razmi
DOI:10.1002/hlca.201400331
日期:2015.6
Nanoscale Pd supported on ZnO was prepared by a facile coprecipitation method. Pd/ZnO Nanoparticles were characterized by using XRD, TEM, SEM, XPS, BET specific surface area measurement, and thermogravimetric analysis. This catalyst was used as novel and excellent heterogeneouscatalyst for ligand‐free CC bond‐formation particularly in the synthesis of unsymmetrical biaryls by SuzukiMiyaura and Hiyama
An object of the present invention is to provide a process that enables isocyanate to be produced stably over a long period of time and at high yield without encountering problems of the prior art during production of isocyanate without using phosgene. The present invention discloses a process for producing an isocyanate by subjecting a carbamic acid ester to a thermal decomposition reaction, including the steps of: recovering a low boiling point component in a form of a gaseous phase component from a thermal decomposition reaction vessel in which the thermal decomposition reaction is carried out; recovering a liquid phase component containing a carbamic acid ester from a bottom of the thermal decomposition reaction vessel; and supplying all or a portion of the liquid phase component to an upper portion of the thermal decomposition reaction vessel.
PROCESS FOR PRODUCING ISOCYANATES USING DIARYL CARBONATE
申请人:Shinohata Masaaki
公开号:US20110054211A1
公开(公告)日:2011-03-03
An object of the present invention is to provide a process that enables isocyanate to be produced stably over a long period of time and at high yield without encountering problems of the prior art during production of isocyanate without using phosgene. The present invention provides an isocyanate production process including the steps of: obtaining a reaction mixture containing an aryl carbamate having an aryl group originating in a diaryl carbonate, an aromatic hydroxy compound originating in a diaryl carbonate, and a diaryl carbonate, by reacting a diaryl carbonate and an amine compound in the presence of a reaction solvent in the form of an aromatic hydroxy compound; transferring the reaction mixture to a thermal decomposition reaction vessel; and obtaining isocyanate by applying the aryl carbamate to a thermal decomposition reaction, wherein the reaction vessel in which the reaction between the diaryl carbonate and the amine compound is carried out and the thermal decomposition reaction vessel for the aryl carbamate are different.